Your browser doesn't support javascript.
loading
Increased circulating IL-18 levels in severe mental disorders indicate systemic inflammasome activation.
Szabo, Attila; O'Connell, Kevin S; Ueland, Thor; Sheikh, Mashhood A; Agartz, Ingrid; Andreou, Dimitrios; Aukrust, Pål; Boye, Birgitte; Bøen, Erlend; Drange, Ole Kristian; Elvsåshagen, Torbjørn; Engh, John Abel; Hope, Sigrun; Collier Høegh, Margrethe; Joa, Inge; Johnsen, Erik; Kroken, Rune Andreas; Vik Lagerberg, Trine; Lekva, Tove; Malt, Ulrik Fredrik; Melle, Ingrid; Morken, Gunnar; Nærland, Terje; Steen, Vidar Martin; Sørensen, Kjetil; Wedervang-Resell, Kirsten; Auten Weibell, Melissa; Westlye, Lars T; Steen, Nils Eiel; Andreassen, Ole; Djurovic, Srdjan.
Afiliación
  • Szabo A; Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Department of Medical Genetics, Oslo University Hospital, Oslo, Norway. Electronic address: attila.szabo@medisin.uio.no.
  • O'Connell KS; Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Ueland T; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; K.G. Jebsen Thrombosis Research and Expertise Center, University of Tromsø, Tromsø, Norway.
  • Sheikh MA; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.
  • Agartz I; Norwegian Centre for Mental Disorders Research, NORMENT, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Stockholm Region, Stockholm, Sweden; Department
  • Andreou D; Norwegian Centre for Mental Disorders Research, NORMENT, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Stockholm Region, Stockholm, Sweden.
  • Aukrust P; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway.
  • Boye B; Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway; Psychosomatic and Consultation-liason Psychiatry, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Bøen E; Psychosomatic and Consultation-liason Psychiatry, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Drange OK; Department of Mental Health, Norwegian University of Science and Technology, NTNU, Trondheim, Norway; Department of Østmarka, Division of Mental Health, St. Olavs University Hospital, Trondheim, Norway; Department of Psychiatry, St Olav University Hospital, Trondheim, Norway.
  • Elvsåshagen T; Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Engh JA; Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
  • Hope S; Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Department of Neuro Habilitation, Oslo University Hospital Ullevål, Oslo, Norway.
  • Collier Høegh M; Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Joa I; TIPS, Centre for Clinical Research in Psychosis, Stavanger University Hospital, Stavanger, Norway; Network for Medical Sciences, Faculty of Health, University of Stavanger, Stavanger, Norway.
  • Johnsen E; Division of Psychiatry, Haukeland University Hospital, Bergen, Norway; NORMENT, Department of Clinical Science, University of Bergen, Bergen, Norway; Dr. Einar Martens Research Group for Biological Psychiatry, Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.
  • Kroken RA; Division of Psychiatry, Haukeland University Hospital, Bergen, Norway; NORMENT, Department of Clinical Science, University of Bergen, Bergen, Norway; Dr. Einar Martens Research Group for Biological Psychiatry, Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.
  • Vik Lagerberg T; Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Lekva T; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.
  • Malt UF; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Melle I; Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Morken G; Department of Mental Health, Norwegian University of Science and Technology, NTNU, Trondheim, Norway; Department of Psychiatry, St Olav University Hospital, Trondheim, Norway.
  • Nærland T; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; K.G. Jebsen Center for Neurodevelopmental Disorders, Oslo, Norway; Department of Rare Disorders and Disabilities, Oslo University Hospital, Oslo, Norway.
  • Steen VM; NORMENT, Department of Clinical Science, University of Bergen, Bergen, Norway; Dr. Einar Martens Research Group for Biological Psychiatry, Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.
  • Sørensen K; Department of Psychiatry, St. Olav's University Hospital, Trondheim, Norway.
  • Wedervang-Resell K; Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Auten Weibell M; TIPS, Centre for Clinical Research in Psychosis, Stavanger University Hospital, Stavanger, Norway; Network for Medical Sciences, Faculty of Health, University of Stavanger, Stavanger, Norway.
  • Westlye LT; Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; K.G. Jebsen Center for Neurodevelopmental Disorders, Oslo, Norway; Department of Psychology, University of Oslo, Oslo, Norway.
  • Steen NE; Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Andreassen O; Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Djurovic S; Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; NORMENT, Department of Clinical Science, University of Bergen, Bergen, Norway. Electronic address: srdjan.djurovic@medisin.uio.no.
Brain Behav Immun ; 99: 299-306, 2022 01.
Article en En | MEDLINE | ID: mdl-34758379

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Esquizofrenia Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Brain Behav Immun Asunto de la revista: ALERGIA E IMUNOLOGIA / CEREBRO / PSICOFISIOLOGIA Año: 2022 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Esquizofrenia Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Brain Behav Immun Asunto de la revista: ALERGIA E IMUNOLOGIA / CEREBRO / PSICOFISIOLOGIA Año: 2022 Tipo del documento: Article Pais de publicación: Países Bajos